Cas:870837-28-8 Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) manufacturer & supplier

We serve Chemical Name:Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) CAS:870837-28-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl)

Chemical Name:Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl)
CAS.NO:870837-28-8
Synonyms:Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl)
Molecular Formula:C13H14N2O2
Molecular Weight:230.26200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:423.5ºC at 760 mmHg
Density:1.13g/cm3
Index of Refraction:1.568
PSA:44.12000
Exact Mass:230.10600
LogP:2.39190

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) Use and application,Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) technical grade,usp/ep/jp grade.


Related News: ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) manufacturer An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) supplier This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved. Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) vendor This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved. Benzaldehyde, 3-ethoxy-4-(4-methyl-1H-imidazol-1-yl) factory This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.